Challenges & strategies for conducting qualitative research with persons diagnosed with rare movement disorders

Qualitative Report

Volumn , Issue 16, 2014, Pages

  LaDonna, Kori A ^a   Ravenek, Michael J ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Focus groups; Huntington s disease; Interviews; Parkinson s disease; Qualitative research methods; Young Adults

Indexed keywords

EID: 84898883086     PISSN: None     EISSN: 21603715     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Anderson, K. E., & Marder, K. S. (2001). An overview of psychiatric symptoms in Huntington’s disease. Current Psychiatry Reports, 3, 379-388.
2. Bonelli, R., & Hofmann, P. (2004). A review of the treatment options for Huntington’s disease. Expert Opinion on Pharmacotherapy, 5, 767-776.
3. Carlsson, E., Paterson, B. L., Scott-Findlay, S., Ehnfors, M., & Ehrenberg, A. (2007). Methodological issues in interviews involving people with communication impairments after acquired brain damage. Qualitative Health Research, 17(10), 1361-1371.
4. Charmaz, K. (2006). Constructing grounded theory: A practical guide through qualitative analysis. London, UK: Sage.
5. rd ed., pp. 62-94). Oxford, UK: Oxford University Press.
6. Denzin, N. K., & Giardina, M. D. (2009). Qualitative inquiry and social justice. Walnut Creek, CA: Left Coast Press.
7. Dickson-Swift, V., James, E. L., Kippen, S., & Liamputtong, P. (2007). Doing sensitive research: What challenges do qualitative researchers face? Qualitative Research, 7(3), 327-353.
8. DiMaio, L., Squitieri, F., Napolitano, G., Campanella, G., Trofatter, J. A., & Conneally, P. M. (1993). Suicide risk in Huntington’s disease. Journal of Medical Genetics, 30, 293-295.
9. Dubois, B., & Pillon, B. (1996). Cognitive deficits in Parkinson’s disease. Journal of Neurology, 244(1), 2-8.
10. Gelb, D. J., Oliver, E., & Gilman, S. (1999). Diagnostic criteria for Parkinson disease. Archives of Neurology, 56(1), 33-39.
11. Gudesblatt, M., & Tarsy, D. (2011). Huntington’s disease: A clinical review. Supplement to Neurology Reviews, S1-S8.
12. Harper, P. S. (1992). The epidemiology of Huntington’s disease. Human Genetics, 89, 365-376.
13. Hartelius, L., Jonsson, M., Rickeberg, A., & Laasko, K. (2010). Communication and Huntington’s disease: Qualitative interviews and focus groups with persons with Huntington’s disease, family members, and carers. International Journal of Language Communication Disorders, 45(3), 381-393.
14. Huntington, G. (1872). On chorea. The Medical and Surgical Reporter, 26(15), 317-321.
15. Jankovic, J. (2008). Parkinson’s disease: Clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry, 79(4), 368-376.
16. Jankovic, J., & Kapadia, A. S. (2001). Functional decline in Parkinson disease. Archives of Neurology, 58(10), 1611-1615.
17. rd ed., pp. 28-61). Oxford, UK: Oxford University Press.
18. LaDonna, K. A., Landry, T., Johnson, A., & Hyson, H. C. (2009). A snapshot of using photovoice in Huntington’s disease. Clinical Genetics, 76(1), 95.
19. Lloyd, V., Gatherer, A., & Kalsy, S. (2006). Conducting qualitative research with people with expressive language difficulties. Qualitative Health Research, 16(10), 1386-1404.
20. Muangpaisan, W., Hori, H., & Brayne, C. (2009). Systematic review of the prevalence and incidence of Parkinson’s disease in Asia. Journal of Epidemiology, 19(6), 281-293.
21. Nygard, L. (2006). How can we get access to the experiences of people with dementia: Suggestions and reflections. Scandinavian Journal of Occupational Therapy, 13, 101-112.
22. Orphanet. (2012). Prevalence of rare diseases: Bibliographic data. Orphanet Report Series – Rare Diseases Collection, Number 1. Retrieved from http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence:of_rare_diseases_by_alphabetical_list.pdf.
23. Paterson, B., & Scott-Findlay, S. (2002). Critical issues in interviewing people with traumatic brain injury. Qualitative Health Research, 12, 399-409.
24. Paulsen, J. S., Ferneyhough Hoth, K., Nehl, C., Stierman, L., & Group, T. H. S. (2005). Critical periods of suicide risk in Huntington’s disease. The American Journal of Psychiatry, 162(4), 725-731.
25. Paulsen, J. S., Ready, R. E., Hamilton, J. M., Mega, M. S., & Cummings, J. L. (2001). Neuropsychiatric aspects of Huntington’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 71, 310-314.
26. Politis, M., Wu, K., Molloy, S. G., Bain, P., Chaudhuri, K. R., & Piccini, P. (2010). Parkinson’s disease symptoms: The patient’s perspective. Movement Disorders, 25(11), 1646-1651.
27. Quinn, N., Critchley, P., & Marsden, C. D. (1987). Young onset Parkinson’s disease. Movement Disorders, 2(2), 73-91.
28. Rana, A. Q., Siddiqui, I., & Yousuf, M. S. (2012). Challenges in diagnosis of young onset Parkinson’s disease. Journal of the Neurological Sciences, 323(1), 113-116.
29. Ravenek, M. J., & Laliberte Rudman, D. (2013). ’Bridging’ conceptions of quality in ’moments’ of qualitative research. International Journal of Qualitative Methods, 12, 436-456.
30. Roos, R. A. C. (2010). Huntington’s disease: A clinical review. Orphanet Journal of Rare Diseases, 5(40), 2-8.
31. Rudd, M. D., Berman, A. L., Joiner, T. E., Nock, M. K., Silverman, M. M., Mandrusiak, M., White, T. (2006). Warning signs for suicide: Theory, research, and clinical applications. Suicide and Life-Threatening Behavior, 36(3), 255-262.
32. Schrag, A., Ben-Shlomo, Y., & Quinn, N. P. (2000). Cross sectional prevalence survey of idiopathic Parkinson’s disease and Parkinsonism in London. BMJ, 321(7252), 21-22.
33. Schrag, A., Hovris, A., Morley, D., Quinn, N., & Jahanshahi, M. (2003). Young-versus olderonset Parkinson’s disease: Impact of disease and psychosocial consequences. Movement Disorders, 18(11), 1250-1256.
34. Schrag, A., Jahanshahi, M., & Quinn, N. (2000). How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Movement Disorders, 15(6), 1112-1118.
35. Schrag, A., & Quinn, N. (2000). Dyskinesias and motor fluctuations in Parkinson’s disease: A community-based study. Brain, 123(11), 2297-2305.
36. Selikhova, M., Williams, D. R., Kempster, P. A., Holton, J. L., Revesz, T., & Lees, A. J. (2009). A clinico-pathological study of subtypes in Parkinson’s disease. Brain, 132(11), 2947-2957.
37. Sheriff, J. N., & Chenoweth, L. (2003). Challenges in conducting research to improve the health of people with Parkinson’s disease and the well-being of their family carers. International Journal of Rehabilitation Research, 26(3), 201-205.
38. Shoulson, I., & Young, A. B. (2011). Milestones in Huntington’s disease. Movement Disorders, 26(6), 1127-1133.
39. Skirton, H., Soltysiak, B., & Gardiner, P. (2007). Obtaining the patient’s views on care: Methodological and practical challenges in long-term neurological conditions. Nursing & Health Sciences, 9(3), 240.
40. Snowden, J., Craufurd, D., Griffiths, H., Thompson, J., & Neary, D. (2001). Longitudinal evaluation of cognitive disorder in Huntington’s disease. Journal of the International Neuropsychological Society, 7, 33-44.
41. Sturrock, A., & Leavitt, B. R. (2010). The clinical and genetic features of Huntington’s disease. Journal of Geriatric Psychiatry and Neurology, 23, 243-259.
42. The Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucelotide repeat that is expanded and unstable on Huntington’s disease chromosones. Cell, 72, 971-983.
43. Tracy, S. J. (2010). Qualitative quality: Eight “big-tent” criteria for excellent qualitative research. Qualitative Inquiry, 16(10), 837-851.
44. Vitale, C., Pellecchia, M. T., Grossi, D., Fragassi, N., Cuomo, T., Di Maio, L., et al. (2001). Unawareness of dyskinesias in Parkinson’s and Huntington’s diseases. Neurological Sciences, 22(1), 105-106.
45. Wang, C., & Burris, M.A. (1994). Empowerment through photo novella: Portraits of participation. Health Education & Behavior, 21(2), 171-186.
46. Wickremaratchi, M. M., Perera, D., O’loghlen, C., Sastry, D., Morgan, E., Jones, A., Ben-Shlomo Y. (2009). Prevalence and age of onset of Parkinson’s disease in Cardiff: A community based cross sectional study and meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry, 80(7), 805-807.
47. Wiersma, E. C. (2011). Using Photovoice with people with early-stage Alzheimer’s disease: A discussion of methodology. Dementia, 10(2), 203-216.
48. Williams, J. K. & Ayres L. (2007) I’m like you: Establishing, confirming and contesting common ground in focus groups with Huntington disease caregivers. Journal of Research in Nursing, 12, 655–664.
49. Willis, A. W., Schootman, M., Kung, N., & Racette, B. A. (2012). Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson’s Disease in the United States. Parkinsonism & Related Disorders, Early Online, 19(2), 202-206.